Journals / İktisadi İdari ve Siyasal Araştırmalar Dergisi / 2021 / Cilt: 6 - Sayı: 15

COVID-19 Treatment Costs in Turkey: Determinants and Burden of the Social Security Institution

Türkiye’de COVID-19 Tedavi Maliyetleri: Sosyal Güvenlik Kurumuna Yükü ve Belirleyicileri

Pages
262–270
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, it can be said that the cost of treatment for COVID-19 is quite high, the costs of treatment will increase depending on the number of patients receiving treatment for COVID-19, and it can be a significant financial burden on SSI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study aims to investigate the burden of treatment costs of patients hospitalized with COVID-19 on the Social Security Institution (SSI) and determinants of COVID-19 treatment costs.
📊
Key Findings & Data:The study examined 389 patient files that were admitted to a public hospital in Turkey with the diagnosis of COVID-19.
💡
Conclusion & Impact:As a result, it can be said that the cost of treatment for COVID-19 is quite high, the costs of treatment will increase depending on the number of patients receiving treatment for COVID-19, and it can be a significant financial burden on SSI.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tedavi Maliyetleri · Sosyal Güvenlik Kurumu · Türkiye

Abstract

This study aims to investigate the burden of treatment costs of patients hospitalized with COVID-19 on the Social Security Institution (SSI) and determinants of COVID-19 treatment costs. This research is a retrospective study. The study examined 389 patient files that were admitted to a public hospital in Turkey with the diagnosis of COVID-19. In the study, age, unit of hospitalization, gender, the average hospitalization time, chronic disease and invoice amounts were evaluated. The average invoice amount for each patient was calculated as $653.03. The average length of stay is 5.38 days and the average daily invoice amount per person is $121.37. Independent variables of age, hospitalization unit (service, intensive care unit), chronic disease (yes, no) and average hospitalization time (day) accounted for 79.3% of the change in the cost of treatment for COVID-19. As a result, it can be said that the cost of treatment for COVID-19 is quite high, the costs of treatment will increase depending on the number of patients receiving treatment for COVID-19, and it can be a significant financial burden on SSI.

Özet

Bu çalışmanın amacı COVID-19 tanısıyla hastaneye yatan hastaların tedavi maliyetlerinin Sosyal Güvenlik Kurumuna (SGK) yükünü ve COVID-19 tedavi maliyetlerinin belirleyicilerini araştırmaktır. Araştırma retrospektif tipte bir araştırmadır. Araştırmada, Türkiye’de bir kamu hastanesine COVID-19 tanısıyla yatışı yapılan 389 hasta dosyası incelenmiştir. Araştırmada hastaların yaş, yatış yapılan birim, cinsiyet, ortalama yatış süresi, kronik hastalık ve fatura tutarları değerlendirilmiştir. Her bir hasta için ortalama fatura tutarı $653,03 olarak hesaplanmıştır. Ortalama yatış süresi 5,38 gündür ve kişi başı günlük ortalama fatura $121,37’dır. Bağımsız değişkenler olarak belirlenen yaş, yatış yapılan birim (servis, yoğun bakım), kronik hastalık (var, yok) ve ortalama yatış süresi (gün) değişkenlerinin bağımsız değişken olan COVID-19 tedavi maliyetindeki değişimin %79,3’ünü açıkladığı görülmüştür. Sonuç olarak, COVID-19’un tedavi maliyetlerinin oldukça yüksek olduğu, COVID-19 nedeniyle tedavi gören hasta sayısına bağlı olarak tedavi maliyetlerinin yükselebileceği ve SGK'ya önemli bir mali yük olabileceği söylenebilir.

🔖

Cite This Article

EKİNGEN, E., YILDIZ, A. (2022). COVID-19 Treatment Costs in Turkey: Determinants and Burden of the Social Security Institution. İktisadi İdari ve Siyasal Araştırmalar Dergisi, Cilt: 6 - Sayı: 15, 262–270. https://ajindex.com/articles/544317

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Anoushiravani, A.A., O'Connor, C.M., DiCaprio, M.R. and Iorio, R. (2020). Economic impacts of the COVID-19 crisis: An orthopaedic perspective. The Journal of Bone and Joint Surgery, (102), 937-41
  2. Bartsch, S.M., Ferguson, M.C., McKinnell, J.A., O'Shea, K.J., Wedlock, P.T., Siegmund, S.S. and Lee, B.Y. (2020). The potential health care costs and resource use associated with COVID-19 in the United States: A simulation estimate of the direct medical costs and health care resource use associated with COVID-19 infections in the United States. Health Affairs, https://doi.org/10.1377/hlthaff.2020.00426
  3. Beyhun, N.E. and Çilingiroğlu, N. (2004). Hastalık maliyeti ve astım. Tüberküloz ve Toraks Dergisi, 52(4), 386-392
  4. Bonaccorsi, G., Pierri, F., Cinelli, M., Flori, A., Galeazzi, A., Porcelli, F.,. and Pammolli, F. (2020). Economic and social consequences of human mobility restrictions under COVID-19. Proceedings of the National Academy of Sciences, 117(27), 15530-15535 Central Bank of the Republic of Turkey (2020, 13 Ekim). Gösterge Niteliğindeki Merkez Bankası Kurları. https://www.tcmb.gov.tr/kurlar/kurlar_tr.html
  5. Di Gennaro, F., Pizzol, D., Marotta, C., Antunes, M., Racalbuto, V., Veronese, N. and Smith, L. (2020). Coronavirus diseases (COVID-19) current status and future perspectives: A narrative review. International Journal of Environmental Research and Public Health, 17(8), 2690. doi: 10.3390 / ijerph17082690 Sağlık Bakanı Koca: Türkiye'de ilk koronavirüs (Covid-19) vakası tespit edildi. (2020, 15 Nisan). Euronews. https://tr.euronews.com/2020/03/10/sagl-k-bakan-koca-koronavirus-covid-19-salg-n-ile-ilgili-ac-klama-yap-yor
  6. Glied, S. and Levy, H. (2020). The potential effects of coronavirus on national health expenditures. Jama, 323(20), 2001-2002
  7. Guo, Y.R., Cao, Q.D., Hong, Z.S., Tan, Y.Y., Chen, S.D., Jin, H.J.,. and Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medical Research, 7(1), 1-10
  8. İşlek, E., Özatkan, Y., Bilir, M.K., Arı, H.O., Çelik, H. and Yıldırım, H.H. (2020). COVID-19 Pandemi yönetiminde Türkiye örneği: Sağlık politikası uygulamaları ve stratejileri. TÜSPE Yayınları Kooraki, S., Hosseiny, M., Myers, L. and Gholamrezanezhad, A. (2020). Coronavirus (COVID-19) outbreak: What the department of radiology should know. Journal of The American College of Radiology, (7) 447-451
  9. Lai, C.C., Shih, T.P., Ko, W.C., Tang, H.J. and Hsueh, P.R. (2020). Seve